About this trial
The objective of this study is to create a comprehensive, multi-center, TRACK-LVO registry-linked cohort of consecutive patients with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO) and presenting to each participating center beyond 24 hours from last known well, who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).
Eligibility criteria
Qualifiers
Patient admitted from Jan. 1st 2018 to Jan. 1st 2028;
Presenting beyond 24 hours from last known well;
Ischemic stroke confirmed by head CT or MRI;
Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1/P2);
Disqualifiers
None
Trial design
Treatments tested in this trial
- Mechanical Thrombectomy